Ingredion Inc INGR
4 targets with a reported result
Releases of the last 3 yearsThe numbers INGR said it expected, in its earnings releases, next to what it then reported for the same period.
Target by target
Each target, with the sentence it came from · release and 10-Q or 10-K
| Target | What the company said | Reported | Result | |
|---|---|---|---|---|
| Capital expenditures Fiscal 2026 |
Given $400.00M to $440.00M release May 5, 2026
Raised $450.00M to $490.00M release Aug 4, 2026
Kept $450.00M to $490.00M release Nov 5, 2026
|
– | Not reported yet | |
The company's wordsCapital expenditures for the full year are expected to be approximately $400 to $440 million. release May 5, 2026 Capital expenditures for the full year are now expected to be approximately $450 to $490 million. release Aug 4, 2026 Capital expenditures for the full year are still expected to be approximately $450 to $490 million. release Nov 5, 2026 | ||||
| Diluted EPS Fiscal 2026 |
Given $9.60 to $10.30 release May 5, 2026
Lowered $9.15 to $9.75 release Aug 4, 2026
Lowered $8.04 to $8.49 release Nov 5, 2026
|
– | Not reported yet | |
The company's wordsAdjusting full-year guidance for reported EPS to be in the range of $9.60 to $10.30 and adjusted EPS to be in the range of $10.45 to $11.15 release May 5, 2026 Reaffirming amended full-year guidance, which now reflects the sale of a majority stake in the Pakistan business, for reported EPS to be in the range of $9.15 to $9.75 and adjusted EPS to be in the range of $10.30 to $10.90 release Aug 4, 2026 Adjusting full-year guidance for reported diluted EPS to be in the range of $8.04 to $8.49 and adjusted diluted EPS to be in the range of $9.25 to $9.70 release Nov 5, 2026 | ||||
| Diluted EPS (company-defined) Fiscal 2026 |
Given $10.45 to $11.15 release May 5, 2026
Lowered $10.30 to $10.90 release Aug 4, 2026
Lowered $9.25 to $9.70 release Nov 5, 2026
|
– | No standard number | |
The company's wordsAdjusting full-year guidance for reported EPS to be in the range of $9.60 to $10.30 and adjusted EPS to be in the range of $10.45 to $11.15 release May 5, 2026 Reaffirming amended full-year guidance, which now reflects the sale of a majority stake in the Pakistan business, for reported EPS to be in the range of $9.15 to $9.75 and adjusted EPS to be in the range of $10.30 to $10.90 release Aug 4, 2026 Adjusting full-year guidance for reported diluted EPS to be in the range of $8.04 to $8.49 and adjusted diluted EPS to be in the range of $9.25 to $9.70 release Nov 5, 2026 | ||||
| Capital expenditures Fiscal 2025 (ended Dec 31, 2025) |
Given $400.00M to $450.00M release Feb 4, 2025
Lowered $400.00M to $425.00M release Aug 1, 2025
Kept $400.00M to $425.00M release Nov 4, 2025
|
$433.00M 10-K filed 2026-02-17 |
Above the range | |
The company's words2025 Full-Year Outlook … Capital expenditures for the full year are expected to be approximately $400 to $450 million. release Feb 4, 2025 This guidance reflects tariff levels in effect as of the end of July 2025. … Capital expenditures for the full year are expected to be approximately $400 to $425 million. release Aug 1, 2025 Capital expenditures for the full year are expected to be approximately $400 to $425 million. release Nov 4, 2025 | ||||
| Diluted EPS Fiscal 2025 (ended Dec 31, 2025) |
Given $10.93 to $11.63 release May 6, 2025
Raised $11.25 to $11.75 release Aug 1, 2025
Lowered $11.11 to $11.31 release Nov 4, 2025
|
$11.18 10-K filed 2026-02-17 |
Within the range | |
The company's wordsThe Company expects its full-year 2025 reported EPS to be in the range of $10.93 to $11.63 and adjusted EPS to be in the range of $10.90 to $11.60. release May 6, 2025 The Company expects its full-year 2025 reported EPS to be in the range of $11.25 to $11.75 and adjusted EPS to be in the range of $11.10 to $11.60. release Aug 1, 2025 Adjusting full-year guidance for reported EPS to be in the range of $11.11 to $11.31 and adjusted EPS to be in the range of $11.10 to $11.30 release Nov 4, 2025 | ||||
| Diluted EPS (company-defined) Fiscal 2025 (ended Dec 31, 2025) |
Given $10.90 to $11.60 release May 6, 2025
Raised $11.10 to $11.60 release Aug 1, 2025
Lowered $11.10 to $11.30 release Nov 4, 2025
|
– | No standard number | |
The company's wordsUpdated Full-Year 2025 Outlook … The Company expects its full-year 2025 reported EPS to be in the range of $10.93 to $11.63 and adjusted EPS to be in the range of $10.90 to $11.60. release May 6, 2025 Updated Third Quarter and Full-Year 2025 Outlook … The Company expects its full-year 2025 reported EPS to be in the range of $11.25 to $11.75 and adjusted EPS to be in the range of $11.10 to $11.60. release Aug 1, 2025 Adjusting full-year guidance for reported EPS to be in the range of $11.11 to $11.31 and adjusted EPS to be in the range of $11.10 to $11.30 release Nov 4, 2025 | ||||
| Capital expenditures Fiscal 2024 (ended Dec 31, 2024) |
Given $340.00M release Feb 6, 2024
Kept $340.00M release May 8, 2024
Kept $340.00M release Aug 6, 2024
Lowered $310.00M to $330.00M release Nov 5, 2024
|
$301.00M 10-K filed 2025-02-20 |
Below the range | |
The company's words2024 Full-Year Outlook … Capital expenditures for the full year are expected to be approximately $340 million. release Feb 6, 2024 Updated Second Quarter and Full-Year 2024 Outlook … Capital expenditures for the full year are still expected to be approximately $340 million. release May 8, 2024 Updated Third Quarter and Full-Year 2024 Outlook … Capital expenditures for the full year are still expected to be approximately $340 million. release Aug 6, 2024 Updated Full-Year 2024 Outlook … Capital expenditures for the full year are expected to be approximately $310 to $330 million. release Nov 5, 2024 | ||||
| Diluted EPS Fiscal 2024 (ended Dec 31, 2024) |
Given $10.20 to $11.15 release Feb 6, 2024
Narrowed $10.35 to $11.00 release May 8, 2024
Lowered $10.20 to $10.70 release Aug 6, 2024
Raised $10.60 to $10.90 release Nov 5, 2024
|
$9.71 10-K filed 2025-02-20 |
Below the range | |
The company's wordsThe Company expects its full-year 2024 outlook for reported EPS to be in the range of $10.20 to $11.15 and adjusted EPS to be in the range of $9.15 to $9.85, reflecting the impact of the S. Korea business divestiture release Feb 6, 2024 The Company now expects its full-year 2024 reported EPS to be in the range of $10.35 to $11.00, which includes the impact of the gain on the divestiture of the South Korea business completed on February 1, 2024, and adjusted EPS to be in the range of $9.20 to $9.85. release May 8, 2024 The Company now expects its full-year 2024 reported EPS to be in the range of $10.20 to $10.70, which includes the impact of the gain on the sale of the South Korea business completed on February 1, 2024. release Aug 6, 2024 The Company expects its full-year 2024 reported EPS to be in the range of $10.60 to $10.90, which includes the impact of the gain on the sale of our South Korea business. release Nov 5, 2024 | ||||
| Diluted EPS (company-defined) Fiscal 2024 (ended Dec 31, 2024) |
Given $9.15 to $9.85 release Feb 6, 2024
Raised $9.20 to $9.85 release May 8, 2024
Raised $10.35 to $10.65 release Nov 5, 2024
|
– | No standard number | |
The company's wordsThe Company expects its full-year 2024 outlook for reported EPS to be in the range of $10.20 to $11.15 and adjusted EPS to be in the range of $9.15 to $9.85, reflecting the impact of the S. Korea business divestiture release Feb 6, 2024 Updated Second Quarter and Full-Year 2024 Outlook … The Company now expects its full-year 2024 reported EPS to be in the range of $10.35 to $11.00, which includes the impact of the gain on the divestiture of the South Korea business completed on February 1, 2024, and adjusted EPS to be in the range of $9.20 to $9.85. release May 8, 2024 Updated Full-Year 2024 Outlook … The Company now anticipates adjusted EPS to be in the range of $10.35 to $10.65. release Nov 5, 2024 | ||||
| Diluted EPS (company-defined) Q3 of fiscal 2024 |
Given $9.70 to $10.20 release Aug 6, 2024
|
– | No standard number | |
The company's wordsUpdated Third Quarter and Full-Year 2024 Outlook … The Company anticipates adjusted EPS to be in the range of $9.70 to $10.20. release Aug 6, 2024 | ||||
Targets are read from the sentences of the EX-99 exhibits of 8-K item 2.02 filings (12 releases since 2024-02-06), without AI; in outlook tables only the first column is read. The result compares the reported number with the last range given before the period was reported. Results come from SEC's XBRL company facts, as first reported. A company's target can use its own definition (META's capital expenditures include finance lease payments, for example), so read the quote.
Sources
The outlook sentences of each earnings release (8-K item 2.02, exhibit 99), read without AI; results from SEC's XBRL company facts, as first reported.
Also
Earnings releases: each release in full.
Work with it
Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/INGR/export.csv") into a cell.